Treatment of gastrointestinal autonomic neuropathy.

about

Type 1 diabetic patients with peripheral neuropathy have pan-enteric prolongation of gastrointestinal transit times and an altered caecal pH profile.Diabetic Enteropathy: From Molecule to Mechanism-Based Treatment

P2860

Q39010941-61347EB5-8B05-433D-8F05-3D9765999F63 Q57300297-49D3EF59-B98E-4724-BD52-8B19761B3521

P2860

Treatment of gastrointestinal autonomic neuropathy.

Item

http://www.wikidata.org/entity/Q38658415

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Treatment of gastrointestinal autonomic neuropathy.

@en

type

Item

label

Treatment of gastrointestinal autonomic neuropathy.

@en

prefLabel

Treatment of gastrointestinal autonomic neuropathy.

@en

P1476

Treatment of gastrointestinal autonomic neuropathy.

@en

P2093

Hans Törnblom

http://www.w3.org/2001/XMLSchema#string

P2860

Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus

Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults.

Metoclopramide to treat gastroparesis due to diabetes mellitus: a double-blind, controlled trial.

The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis.

A placebo-controlled trial of prucalopride for severe chronic constipation.

Effect of prucalopride on symptoms of chronic constipation.

A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression.

Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.

Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study.

Imipramine treatment improves cognitive outcome associated with enhanced hippocampal neurogenesis after traumatic brain injury in mice

P2888

s00125-015-3828-9

P304

409-413

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00125-015-3828-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1024355753

http://www.w3.org/2001/XMLSchema#string

P698

26634570

http://www.w3.org/2001/XMLSchema#string

Treatment of gastrointestinal autonomic neuropathy.

about

P2860

P2860

Treatment of gastrointestinal autonomic neuropathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698